(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 25.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Dyadic International's revenue in 2025 is $3,554,344.On average, 1 Wall Street analysts forecast DYAI's revenue for 2025 to be $126,380,776, with the lowest DYAI revenue forecast at $126,380,776, and the highest DYAI revenue forecast at $126,380,776. On average, 1 Wall Street analysts forecast DYAI's revenue for 2026 to be $165,498,636, with the lowest DYAI revenue forecast at $165,498,636, and the highest DYAI revenue forecast at $165,498,636.
In 2027, DYAI is forecast to generate $210,634,627 in revenue, with the lowest revenue forecast at $210,634,627 and the highest revenue forecast at $210,634,627.